Cancer Biopsy Market Revenue 2025 to 2034
Cancer Biopsy Market Revenue 2025 to 2034
Cancer Biopsy Market (By Product: Instruments, Kits and Consumables, and Services; By Type: Tissue Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Needle Biopsies, Surgical Biopsies, Liquid Biopsies, and Others; By Application; By Region: North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 36.55 Bn
Forecast Year, 2034
USD 196.68 Bn
CAGR, 2025 - 2034
18.33%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The cancer biopsy market is rapidly expanding, driven by rising cancer prevalence and advances in minimally invasive diagnostics. Valued at USD 36.55 billion in 2025, it is projected to soar to USD 196.68 billion by 2034 at an 18.33% CAGR.
Cancer Biopsy Market Size Analysis
Cancer Biopsy Market Size By_Product 2025 to 2034 (USD Billion)
| By_Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Instruments | 16.45 | 19.49 | 23.85 | 28.85 | 34.92 | 43.87 | 52.05 | 60.75 | 73.14 | 87.27 |
| Kits and Consumables | 12.79 | 14.82 | 17.09 | 20.35 | 23.72 | 27.01 | 31.02 | 34.63 | 42.13 | 51.34 |
| Services | 7.31 | 8.94 | 10.23 | 11.36 | 13.02 | 13.92 | 17.27 | 23.35 | 25.22 | 27.63 |
Cancer Biopsy Market Size By_Type 2025 to 2034 (USD Billion)
| By_Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Tissue Biopsies | 10.96 | 13.39 | 17.58 | 21.58 | 26.10 | 32.19 | 34.72 | 38.79 | 46.21 | 52.79 |
| Fine Needle Aspiration (FNA) | 3.65 | 3.83 | 3.46 | 4.06 | 2.29 | 1.27 | 0.10 | 0.95 | 0.29 | 0.17 |
| Core Needle Biopsy (CNB) | 6.58 | 7.58 | 9.68 | 11.39 | 13.98 | 15.88 | 19.77 | 26.53 | 31.69 | 35.72 |
| Needle Biopsies | 2.56 | 2.52 | 1.03 | 0.06 | 0.07 | 0.64 | 3.37 | 3.83 | 0.14 | 3.20 |
| Surgical Biopsies | 5.48 | 8.14 | 8.72 | 9.71 | 10.54 | 14.01 | 15.91 | 22.10 | 25.57 | 31.25 |
| Liquid Biopsies | 5.48 | 6.52 | 8.34 | 9.57 | 12.23 | 13.54 | 17.46 | 14.16 | 17.78 | 19.22 |
| Others | 1.83 | 1.26 | 2.36 | 4.19 | 6.45 | 7.25 | 9.01 | 12.37 | 18.82 | 23.90 |
Cancer Biopsy Market Size By_Region 2025 to 2034 (USD Billion)
| By_Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 14.62 | 17.35 | 21.13 | 24.02 | 27.90 | 32.94 | 38.47 | 46.48 | 55.67 | 65.40 |
| Asia Pacific | 10.97 | 12.50 | 15.36 | 17.54 | 20.88 | 25.49 | 30.23 | 33.96 | 39.09 | 47.14 |
| Europe | 7.31 | 8.82 | 9.75 | 11.24 | 13.54 | 15.45 | 20.59 | 23.88 | 27.55 | 33.04 |
| LAMEA | 3.66 | 4.58 | 4.94 | 7.76 | 9.34 | 10.92 | 11.04 | 14.40 | 18.19 | 20.67 |
Cancer Biopsy Market Size to Worth USD 196.68 Billion by 2034
The cancer biopsy market size accounted for USD 36.55 billion in 2025 and is predicted to touch around USD 196.68 billion by 2034 at a CAGR of 18.33%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
